ANTISTAX 360 mg, coated tablet 30 tablets
Active ingredients: VIGNE ROUGE (FEUILLE DE) (EXTRAIT SEC DE)
Commercialized according to BDPM
Coated tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ANTISTAX 360 mg, comprimé enrobé
- Pharmaceutical form
- comprimé enrobé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC PVDC aluminium de 30 comprimé(s)
- Marketing authorisation holder
- EG LABO - LABORATOIRES EUROGENERICS
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 23 Jan 2025
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65548973CIP72771569CIP133400927715693Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| VIGNE ROUGE (FEUILLE DE) (EXTRAIT SEC DE)comprimé | 360 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.